Adults 18 to 50, female only, with Diabetes Mellitus, Type 1 or Contraception. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Women 'Prepared for Pregnancy\Primary· 1 hour
Quantitative data - Number of women 'prepared for pregnancy - HbA1C \<48mmol/mol, on folic acid, on no teratogenic medications
Group
Value
95% CI
Participants 'Prepared for Pregnancy'
3
Number of Women Aware of the Importance of Good Glycaemic Control Prior to PregnancySecondary· 1 hour
Quantitative - Number of women aware of the importance of good glycaemic control prior to pregnancy
Group
Value
95% CI
Participants
69
Number of Women Who Had Attended Pre-conception CounsellingSecondary· 1 hour
Quantitative - Number of women who had attended pre-conception counselling
Group
Value
95% CI
Participants
17
Number of Women Aware of Risks to the Foetus in Pregnancy in Women With DiabetesSecondary· 1 hour
Quantitative - Number of women aware of risks to the foetus in pregnancy in women with diabetes
Group
Value
95% CI
Participants
89
Number of Women Aware of Any Risks to the Mother in Pregnancy With Pre-gestational DiabetesSecondary· 1 hour
Quantitative - number of women aware of any risks to the mother in pregnancy with pre-gestational diabetes
Group
Value
95% CI
Participants
80
Sponsor's own description
This study seeks to expand upon and update this body of work. It will explore the knowledge and understanding women with diabetes have around pregnancy and conception, as well as establish how well prepared these women are for a pregnancy. Using this data, we will develop better services to inform women with diabetes about the contraception and pregnancy, as well inform the development of pre-conception counselling services for women with diabetes. If successful, we would anticipate seeing an improvement in performance in future National Diabetes in Pregnancy audits.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Other recruiting trials for Diabetes Mellitus, Type 1
Currently open trials in the same condition.
NCT07325461 — Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes
· NA
· recruiting
NCT07305805 — A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes
· Phase 1
· recruiting
NCT06282055 — Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes
· recruiting
NCT06325202 — Closed Loop and Education for Hypoglycemia Awareness Restoration
· NA
· recruiting
NCT07160816 — A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar
· recruiting
Other Imperial College London trials
Trials by the same sponsor.
NCT06035861 — Endothelial Cell Activation and Total Pulmonary Resistance in PAH
· NA
· not yet recruiting
NCT07397455 — Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron Subvariants
· Phase 1
· not yet recruiting
NCT07422532 — A Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing
· NA
· not yet recruiting
NCT07389031 — Maralixibat for Intrahepatic Cholestasis of Pregnancy
· Phase 2
· not yet recruiting
NCT07358897 — Gender Affirming Hormone Therapy and Immune Function in Trans Individuals - The GIFT Study
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Imperial College London
Last refreshed: 23 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04523454.